Concepedia

Chantal Laframboise

CL

Statistics

Publications

4

Citations

367

H-Index

4

Active since

2004

Affiliations

IQVIA (United States)(Current)

Chantal Laframboise is an author at IQVIA (United States) specializing in pharmacology, immunology, and pharmacokinetic parameters.

Publications per year

2004–2019

4

Publications

4

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Vaccine · 2004 · 245 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial

Nikhil Chauhan, Mary F. Mulcahy, Riad Salem et al. · JMIR Research Protocols · 2019 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety, Pharmacokinetics and Immune Effects in Normal Volunteers of CPG 10101 (ACTILON™), an Investigational Synthetic Toll-like Receptor 9 Agonist

Alain Vicari, Tess Schmalbach, Julie Lekstrom-Himes et al. · Antiviral Therapy · 2007 · 39 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.

Alain Vicari, Tess Schmalbach, Julie Lekstrom-Himes et al. · PubMed · 2007 · 39 citations

Life Sciences, Immunology, Pharmacology +13

1–4 of 4